Brief: Algorae Pharmaceuticals Says First Version Of Algoraeos AI Platform On Schedule And Anticipated By Q3 Of 2024
08/03/2024 01:32
March 8 (Reuters) - Algorae Pharmaceuticals Ltd
1AI.AX :
* FIRST VERSION OF ALGORAEOS AI PLATFORM ON SCHEDULE AND
ANTICIPATED BY Q3 OF 2024
Further company coverage: 1AI.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Algorae Pharmaceuticals
See all newsBrief: Algorae Pharmaceuticals Executes License & Supply Agreement With Torrent Pharma
Brief: Algorae Pharmaceuticals And Zydus Enter Exclusive Commercial Agreement
Brief: Algorae Pharmaceuticals Raises A$3.9 Million At A$0.012 Per Share
Brief: Algorae Pharmaceuticals Says TGA Accepts Initial Registration Dossier For Evaluation
Brief: Algorae Pharmaceuticals Partners With Peter Maccallum Cancer Centre For Second AI-Driven Drug Synergy Screening Program